16-01-2022, 08:14 AM
(15-01-2022, 09:33 PM)Teeth53 Wrote: Warned....![]()
Warned - overly frequent could potentially lead to "problems with immune response."
Reports of the serious neurological illness were also at the heart of trial halts in the early stages of development for both AstraZeneca and J&J’s.
Read more: https://newsinfo.inquirer.net/1540620/em...z7I5VJmmWS
Follow us: @inquirerdotnet on Twitter | inquirerdotnet on Facebook